Friday, July 10, 2026

Intelligence · Clinical pipeline

Autoimmune & immunology · Approved programs

Autoimmune & immunology programs at Approved programs — ClinicalTrials.gov pipeline intelligence.

Programs 84

Quick answer

Autoimmune & immunology Approved programs programs: NovaPharmaNews indexes 84 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.

Top sponsors

Pipeline programs

Page 1 of 2
  1. 2024-517112-30-00

    Disc Medicine

    Rheumatoid arthritis

    approved small molecule active

    1 trial
  2. 300128

    HALEON AUSTRALIA PTY LTD

    Mild/non-serious osteoarthritis (OA) of the knee.

    approved small molecule active

    1 trial
  3. ABBV-066, DEUCRAVACITINIB

    AbbVie Deutschland GmbH & Co. KG

    Plaque Psoriasis

    approved small molecule active

    1 trial
  4. ADALIMUMAB , INFLIXIMAB

    Disc Medicine

    Crohn's disease Ulcerative colitis

    approved small molecule active

    1 trial
  5. ADIPGEN

    The George Institute

    Knee Osteoarthritis

    approved small molecule active

    1 trial
  6. APHP 190183

    Pari Pharma GmbH

    Crohn’s disease

    approved small molecule active

    1 trial
  7. Adalimumab

    Takeda

    Crohn's Disease

    approved small molecule active

    1 trial
  8. Alofisel 5 × 106 cells/mL dispersion for injection.

    Takeda

    Perianal fistulising Crohn´s disease

    approved small molecule active

    1 trial
  9. Baricitinib 4 MG

    Chinese University of Hong Kong

    Rheumatoid Arthritis

    approved small molecule active

    1 trial
  10. Benlysta 200 mg solution for injection in pre-filled pen.

    GlaxoSmithKline

    Systemic Lupus Erythematosus

    approved small molecule active

    1 trial
  11. Buprenorphine transdermal patch

    Mundipharma Pty Limited

    Osteoarthritis

    approved small molecule completed

    1 trial
  12. CAIN457I2401

    Novartis Pharmaceuticals

    non-radiographic axial spondyloarthritis

    approved small molecule active

    1 trial
  13. CDPATH™

    Takeda

    Crohn's Disease

    approved other active

    1 trial
  14. CNTO1959PSA4002

    Janssen-Cilag International N.V.

    Psoriatic Arthritis

    approved small molecule active

    1 trial
  15. Caffeine

    Takeda

    Colitis, Ulcerative

    approved small molecule terminated

    1 trial
  16. Celecoxib

    Pfizer

    Arthritis, Juvenile Rheumatoid

    approved small molecule completed

    1 trial
  17. Cholecalciferol

    United Therapeutics Europe Ltd

    Crohn Disease

    approved other active

    1 trial
  18. Colquhounia Root Tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rheumatoid Arthritis

    approved small molecule active

    1 trial
  19. Darvadstrocel

    Takeda

    Crohn's Disease

    approved mab terminated

    3 trials
  20. DePuy ASR Hip System

    International Peace Maternity and Child Health Hospital

    Rheumatoid Arthritis

    approved other terminated

    1 trial
  21. Dexamethasone

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Localized Primary Osteoarthritis of Both Hips (Diagnosis)

    approved small molecule active

    1 trial
  22. ETN Alone

    Universal Integrated

    Rheumatoid Arthritis

    approved small molecule completed

    1 trial
  23. Enbrel powder and solvent for Juvenile Idiopathic Arthritis

    Fondazione Telethon ETS

    Juvenile Idiopathic Arthritis

    approved small molecule active

    1 trial
  24. Etanercept

    Pfizer

    Moderate to Severe Psoriasis

    approved small molecule completed

    1 trial
  25. Etanercept , Methotrexate

    Wyeth is now a wholly owned subsidiary of Pfizer

    Rheumatoid Arthritis

    approved small molecule completed

    1 trial
  26. Filgotinib

    Lakefront Biotherapeutics NV

    Rheumatoid Arthritis

    approved small molecule active

    8 trials
  27. Foliumzuur Aurobindo for Psoriatic arthritis

    Disc Medicine

    Psoriatic arthritis

    approved small molecule active

    1 trial
  28. GadoCrohn

    The George Institute

    Perianal fistula associated with Crohn's disease

    approved small molecule active

    1 trial
  29. Guli capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Knee Osteoarthritis

    approved small molecule active

    1 trial
  30. Guselkumab

    Janssen Cilag International NV

    Arthritis, Psoriatic

    approved small molecule active

    3 trials
  31. I4V-MC-JAJA

    Eli Lilly Co.

    Rheumatoid Arthritis

    approved small molecule active

    1 trial
  32. I6T-MC-AMCA

    Eli Lilly Co.

    severely active ulcerative colitis (US) and CD (Crohn’s disease)

    approved small molecule active

    1 trial
  33. IDEA

    CERO THERAPEUTICS HOLDINGS, INC.

    Ulcerative Colitis

    approved small molecule active

    1 trial
  34. IM011-1130

    Bristol-Myers Squibb Australia Pty Ltd

    Moderate to Severe Plaque Psoriasis

    approved small molecule active

    1 trial
  35. Infliximab

    The First People's Hospital of Lianyungang

    Crohn's Diseases

    approved small molecule active

    1 trial
  36. Ixekizumab

    Hospital Authority, Hong Kong

    Plaque Psoriasis

    approved mab active

    1 trial
  37. KCT23/2022-ZOOM-IN

    Novo Nordisk A/S

    Knee osteoarthritis

    approved small molecule active

    1 trial
  38. Kineret 100 mg/0.67 ml solution for injection in pre-filled syringe.

    Disc Medicine

    autoimmune disorders, joint disorders synonym: Still's disease, systemic JIA

    approved small molecule active

    1 trial
  39. LCS® Complete™ Mobile Bearing Knee Systems

    International Peace Maternity and Child Health Hospital

    Knee Osteoarthritis

    approved other completed

    1 trial
  40. LP0160-1329

    LEO Pharma A/S

    Moderate-to-severe plaque psoriasis and a body weight ≥120 kg.

    approved small molecule active

    1 trial
  41. MMX Mesalamine

    Takeda

    Ulcerative Colitis

    approved small molecule completed

    2 trials
  42. MMX mesalamine/ mesalazine

    Takeda

    Ulcerative Colitis

    approved small molecule completed

    1 trial
  43. Mesalazine

    The First People's Hospital of Lianyungang

    Ulcerative Colitis, Unspecified

    approved small molecule active

    1 trial
  44. Methotrexate

    United Therapeutics Europe Ltd

    Psoriatic Arthritis

    approved small molecule completed

    1 trial
  45. Methotrexate plus sulfasalazine

    Hospital Authority, Hong Kong

    Rheumatoid Arthritis

    approved small molecule terminated

    1 trial
  46. Methylprednisolone and Mycophenolate mofetil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Autoimmune Hepatitis

    approved small molecule active

    1 trial
  47. NORD-STAR

    The George Institute

    Rheumatoid Arthritis

    approved small molecule active

    1 trial
  48. PRIMERA001

    Disc Medicine

    Rheumatoid arthritis according to 2010 criteria

    approved small molecule active

    1 trial

Frequently asked questions

How many autoimmune & immunology Approved programs programs exist?

84 programs match both the therapeutic area and stage filters in our published index.